Microbiology and Virology
Shop By
-
Recombinant Human SARS-CoV-2 Spike Protein RBD
- Species: SARS-CoV-2
- Bioactivity: 1. Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 5.0 μg/mL can bind Recombinant Human ACE-2 Protein (rp176242) with the EC50 of 75.79 ng/mL. 2. Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 1.0 μg/mL can bind Regdanvimab (anti-Spike RBD) (Ab182925) with the EC50 of 12.65 ng/mL. 3. Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 1.0 μg/mL can bind Imdevimab (anti-Spike RBD) (Ab182897) with the EC50 of 7.82 ng/mL. 4. Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 1.0 μg/mL can bind Etesevimab (anti-Spike RBD) (Ab182932) with the EC50 of 23.96 ng/mL. 5. Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 1.0 μg/mL can bind Sotrovimab (anti-Spike RBD) (Ab182938) with the EC50 of 41.33 ng/mL. 6. Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD (rp155929) at 1.0 μg/mL can bind Casirivimab (anti-Spike RBD) (Ab182896) with the EC50 of 10.50 ng/mL.
Synonyms: SARS-CoV-2 RBD Protein | SARS-CoV-2 Spike RBD Protein | SARS-CoV-2 S Protein RBD -
Recombinant EN-TEV Protease Protein
- Species: Tobacco etch virus(TEV)
- Bioactivity: Measured by its ability to cleave a fusion protein containing the recognition sequence Glu-Asn-Leu-Tyr-Phe-Gln-Gly/Ser , with the cleavage point after Gln. One unit of TEV protease cleaves > 85% of 3 μg of control substrate in 1 hour at pH 8.0 at 30°C.It is recommended that the cleavage for each fusion protein be optimized by varying the amount of Recombinant Viral TEV Protease, reaction time, or incubation temperature.Complete digestion of 50µg of fusion KGF-MBP tag protein using 1µg TEV enzyme (in 1/50 ratio) in either 1 hours at 30 °C or overnight at 4 °C. The "standard" reaction buffer for TEV protease is 50 mM Tris-HCl (pH 8.0), 0.5 mM EDTA and 1mM DTT.
Synonyms: NIa | P1 Protease | TEV Protease | Tobacco Etch Virus Protease -
Recombinant Human TEM8/ANTXR1 Protein
- Species: Human
- Accession #: Q9H6X2-2
- Bioactivity: Measured by its binding ability in a functional ELISA. When Anthrax Protective Antigen is coated at 1.5 μg/mL (100 μL/well), the concentration of Recombinant Human TEM8/ANTXR1 that produces 50% optimal binding response is 0.6-3.6 μg/mL.
Synonyms: ANTXR1 | anthrax toxin receptor 1 | ATR2310008J16Rik | FLJ10601 | FLJ11298 | FLJ21776 | TEM8 | TEM82810405N18Rik | Tu... -
Recombinant Human PGLYRP1/PGRP-S Protein
- Species: Human
- Accession #: O75594
- Bioactivity: Measured by its binding ability in a functional ELISA. When peptidoglycan is coated at 1 µg/mL (100 µL/well), the concentration of Recombinant Human PGLYRP1/PGRP-S that produces 50% optimal binding response is 0.75-4.5 ng/mL.
Synonyms: Peptidoglycan recognition protein short | PGRP-S | peptidoglycan recognition protein 1 | Peptidoglycan recognition pr... -
Recombinant Alkali-tolerant Protein ACas#: 91932-69-5
- Species: Staphylococcus aureus
Synonyms: Protein A | Staphylococcal Protein A | Staphylococcal Protein A Recombinant | Immunoglobulin G-binding protein A | gG... -
Recombinant Influenza A Virus H3N2 Hemagglutinin Protein
- Species: Influenza A
- Bioactivity: Measured by its binding ability in a functional ELISA. When Recombinant Human Galectin-1 immobilized at 10.00 μg/mL, 100 μL/well, the concentration of Recombinant Influenza A Virus H3N2 Hemagglutinin His-tag that produces 50% of the optimal binding response is 0.35-3.50 μg/mL.
Synonyms: HA | Hemagglutinin | Influenza A H3 | Influenza A virus
